Loss of merlin-p85 protein complex in NF2-related tumors

International Journal of Oncology

Volumn 12, Issue 5, 1998, Pages 1073-1078

  Takeshima, Hideo ^a   Nishi, Toru ^a   Yamamoto, Keizo ^a   Kino, Takeshi ^a   Nakamura, Hideo ^a   Saya, Hideyuki ^a   Kochi, Masato ^a   Kuratsu, Jun Ichi ^a   Ushio, Yukitaka ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Biotin; Meningioma; NF2; p85; Vestibular schwannoma

Indexed keywords

BIOTIN; CELL PROTEIN; COMPLEMENTARY DNA; GENE PRODUCT; POLYADENYLATED RNA; PROTEIN P85; UNCLASSIFIED DRUG;

ACOUSTIC NEURINOMA; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; DNA SEQUENCE; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTRACRANIAL TUMOR; NERVE CELL CULTURE; NEURILEMOMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

EID: 0031955508     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Eldridge R: Central neurofibromatosis with bilateral acoustic neuroma. Adv Neurol 29: 57-65, 1981.
2. Martuza RL and Eldridge R: Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). N Engl J Med 31: 684-688, 1988.
3. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, Haase VH, Ambrose CM, Munroe D, Bove C, Haines JL, Martuza RL, MacDonald ME, Seizinger BR, Short MP, Buckler AJ and Gusella JF: A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72: 791-800, 1993.
4. Rouleau GA, Morel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B, Pulst SM, Lenoir G, Bijlsma E, Fashold R, Dumanski J, de Jong P, Parry D, Eldridge R, Aurias A, Delattre O and Thomas G: Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363: 515-521, 1993.
5. Takeshima H, Izawa I, Lee PS, Safdar N, Levin VA and Saya H: Detection of cellular proteins that interact with the NF2 tumor suppressor gene product. Oncogene 9: 2135-2144, 1994.
6. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
7. Rubio MP, Correa KM, Ramesh V, MacCollin MM, Jacoby LB, Deimling VA, Gusella JF and Louis DN: Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas. Cancer Res 54: 45-47, 1994.
8. Hoang-Xuan K, Merel P, Vega F, Hugot JP, Cornu P, Delattre JY, Poisson M, Thomas G and Delattre O: Analysis of the NF2 tumorsuppressor gene and of chromosome 22 deletions in gliomas. Int J Cancer 60: 478-481, 1995.
9. Flesch B, Ntambi E and Neppert J: Biotinylation: a non-radioactive method for the identification of cell surface antigens in immunoprecipitates. Electrophoresis 16: 757-762, 1995.
10. Bayer EA and Wilchek M: The use of the avidin-biotin complex as a tool in molecular biology. Methods Biochem Anal 26: 1-45, 1980.
11. Green NM: Avidin. Adv Protein Chem 29: 85-133, 1975.
12. De Vitis LR, Tedde A, Vitelli F, Ammannati F, Mennonna P, Bigozzi U, Montali E and Papi L: Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas. Hum Genet 97: 632-637, 1996.
13. Sainz J, Figueroa K, Baser ME and Pulst SM: Identification of three neurofibromatosis type 2 (NF2) gene mutations in vestibular schwannomas. Hum Genet 97: 121-123, 1996.
14. Jacoby LB, MacCollin M, Louis DN, Mohney T, Rubio MP, Pulaski K, Trofatter JA, Kley N, Seizinger B, Ramesh V and Gusella JF: Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 3: 413-9, 1994.
15. Merel P, Khe HX, Sanson M, Bijlsma E, Rouleau G, Laurent-Puig P, Pulst S, Baser M, Lenoir G, Sterkers JM, Philippon J, Resche F, Mautner VF, Fischer G, Hulsebos T, Aurias A, Delettre O and Thomas G: Screening for germ-line mutations in the NF2 gene. Genes Chromosom Cancer 12: 117-127, 1995.
16. Arakawa H, Hayashi N, Nagase H, Ogawa M and Nakamura Y: Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers. Hum Mol Genet 3: 565-568, 1994.
17. Bianchi AB, Hara T, Ramesh V, Gao J, Klein SA, Morin F, Menon AG, Trofatter JA, Gusella JF, Seizinger BR and Kley N: Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nat Genet 6: 185-192, 1994.
18. Pykett MJ, Murphy M, Harnish PR and George DL: The neurofibromatosis 2 (NF2) tumor suppressor gene encodes multiple alternatively spliced transcripts. Hum Mol Genet 3: 559-564, 1994.
19. Nishi T, Takeshima H, Hamada K, Yoshizato K, Koga H, Sato K, Yamamoto K, Kitamura I, Kochi M, Kuratsu J, Saya H and Ushio Y: Neurofibromatosis 2 gene has novel alternative splicings which control intracellular protein binding. Int J Oncol 10: 1025-1029, 1997.
20. Cowell JK, Bia B and Akoulitchev A: A novel mutation in the promoter region in a family with a mild form of retinoblastoma indicates the location of a new regulatory domain for the RB1 gene. Oncogene 12: 431-436, 1996.
21. Bird AP: CpG-rich islands and the function of DNA mrthylation. Nature 321: 209-213, 1986.